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Introduction
Neural Crest Cells (NCC) have long been recognized as the fourth
layer of developing vertebrate embryos. The neural crest is a transient
cell population that is probably heterogeneous but multipotent, giving
rise to melanocytes, Schwann cells, sympathetic, parasympathetic and
enteric neurons, enteric glia, endocrine cells, fibroblasts, muscle, bone,
cartilage and meninges, among others cell types [1]. The disorders that
stem from neural crest dysfunction, called Neurocristopathies (NCP)
[2], are still only partially understood. Despite the great advances in
our understanding of NCC formation and development, the causal link
leading to NCP has remained elusive. In a recent review dealing with
NCP [2] we provided a thorough analysis of 66 NCP associated with a
dozen “Cell Signaling Pathways”, 4 different “families of Transcription
Factors” and a wide diversity of “cellular processes”. In over 5 model
organisms (mouse, chicken, frog, fish and others, it has been
demonstrated that NCP are linked to NCC faults during essential
developmental processes. We also discussed the incorporation of new
diseases or syndromes based on the defects of neural crest-derived
tissues and organs that have also been unveiled very recently. In the
light of recent discoveries we also included RASopathies, Ciliopathies,
Ribosomopathies and defective epigenetic mechanisms as responsible
for four newly established NCP categories.
Developmental Insight
Our recent review of NCP [2] also contributed to the understanding
of the role of NCP in the development of different organs. A group of
newly found neural crest derivatives were catalogued and described.
Moreover, the recent advances in the field of neural crest
developmental studies added to the review provide the basis for the
proposal of a new general classification of NCP. This new classification,
based on the axial origin of the neural crest derivatives, is more
comprehensive and easier to understand and represents a guide to
identify the possible origin of an NCP.
The Making of Hematopoietic Precursors
Our NCP review [2] also took into account an old proposal that
considers hematopoietic precursors as derived from a common
intermediate progenitor, the NCCs. This idea arose in part from the
observation that hematopoietic precursors and their lymphoid
progenitors are supported by the finding that the adult bone marrow
microenvironmental niches are composed of various stromal cells,
sympathetic non- myelinating glial Schwann cells and sympathetic
nerve fibers. Since NCCs contribute to the development of all three,
they are present in the human adult bone marrow to generate or
regulate hematopoietic precursors [3,4]. The myelinating and non-
myelinating Schwann cells of all adult nerves originate from the NC
progenitors [5]. The deep revision of the current state on neural crest
research still raises intriguing issues about the possible origin of
hematopoietic precursors and other special cell types or tissues, and
provides new hope that we may someday understand the anemia
group of congenital abnormalities.
Molecular Determinants of the Causes of NCP
While several genetic and nongenetic factors have been linked to
NCP, the underlying molecular mechanisms that are disturbed during
the development of NCC are not completely understood yet. As
mentioned in the NCP review [2], this article can be thought of as an
effort to value the essential research in the model organisms to increase
the understanding of the molecular defects responsible for the
causation of NCP. Therefore, identifying additional genes that also
participate in the molecular mechanisms operating during normal
development may uncover new candidate genes that can be added to
genetic screenings for newborns at risk.
Remaining Questions
Probably the most important question is whether or not all the
tissues and organs derived from the NCC have been discovered
already. Another important issue is if all pathologies caused by the
developmental failure of the NCC are currently known. The research
for formally assessing or answering these questions is challenging in
humans. Work on NCP [2] provides hints for new research as well as
insights into the origin of these pathologies. One of the potential
limitations in this field it is to find the appropriate organism to model
the human disease of interest, and throughout its analysis to reach a
better understanding of the molecular mechanism for the pathogenesis
of NCP. It has been shown that the potential role for a gene suggested
in one organism could be slightly different in another one (or in
humans). More research with different model organisms could be
essential to further pinpoint the molecular causes of NCP. Another
potential problem is the step of extrapolating to human potential
therapies that are successful in model organisms or human cell line
cultures.
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